In this issue of Cell Reports Medicine, Wang et al.1 generated 160 human lung cancer organoids, primarily from malignant effusions, and tested their responses to clinically used drugs to determine whether the ex vivo organoid responses predicted patient responses.

Original languageEnglish (US)
Article number100952
JournalCell Reports Medicine
Issue number2
StatePublished - Feb 21 2023

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Moving toward precision medicine with lung cancer organoids'. Together they form a unique fingerprint.

Cite this